Peanut Oral Immunotherapy at Younger Age Ups Desensitization in Children
More children who received immunotherapy met the primary outcome of desensitization and remission criteria
Allergic Disorders
Ryaltris Nasal Spray Approved for Seasonal Allergic Rhinitis
Ryaltris is a metered, fixed-dose nasal spray that delivers 665mcg of olopatadine hydrochloride and 25mcg of mometasone furoate in each spray.
New Drugs Approved in 2021
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
FDA Denies Approval of Novel Budesonide Formulation for Eosinophilic Esophagitis
The FDA stated that the application could not be approved in its present form and recommended an additional clinical study.
Ligelizumab Not Superior to Omalizumab in Chronic Spontaneous Urticaria Trials
Ligelizumab is a high-affinity monoclonal anti-immunoglobulin E antibody.
Allergen Immunotherapy for Allergic Rhinitis Has Favorable Real-World Outcomes
A prospective, single-center study examined the use of allergen immunotherapy for alleviating the burden of allergic rhinitis.
Dextenza Approved for Ocular Itching Associated With Allergic Conjunctivitis
The approval was based on data from three phase 3 studies that evaluated the efficacy and safety of Dextenza in patients with allergic conjunctivitis.
Novel Nasal Saline Irrigation System Improves Compliance, Allergic Rhinitis Symptoms
Study authors evaluated the impact on compliance and SNOT-20 scores in patients with allergic rhinitis using a novel sinus nasal rinse device.
Many With Food Allergy Unaware of Oral Immunotherapy Option
Awareness disproportionately higher among wealthier, more highly educated respondents
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria
